-+ 0.00%
-+ 0.00%
-+ 0.00%
Kura Oncology Names Jennifer Fulk Chief Financial Officer
Share
Listen to the news
Kura Oncology Names Jennifer Fulk Chief Financial Officer
  • Kura Oncology appointed Jennifer Fulk chief financial officer in September 2026.
  • Fulk most recently held senior finance and operating leadership roles at Soleno Therapeutics. She previously spent over 15 years at Eli Lilly.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kura Oncology Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611101602PRIMZONEFULLFEED9874602) on November 10, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending